Results: Quantitative competitive polymerase chain reaction documented a 10-fold increase in the expression of the gene for matrix metalloproteinase 2 in premature rupture of fetal membranes with respect to term and preterm labor.
The intensity of the public reaction documents that climate matching can be a key element in establishing environmental policy, and that differences among approaches to climate modeling are critical for evaluating the scientific basis for the policy.
Results: Multiple polymerase chain reactions and reverse transcriptase polymerase chain reactions documented the induction of Fas and caspase 2, 3, 7, 8, and 9 genes in amniochorion after lipopolysaccharide and tumor necrosis factor stimulation compared with the nonstimulated controls.
FAME has other benefits since it is not just a predictor of CYP metabolism but reflects the broader enzyme reactions documented in the Metabolite database and can be filtered for Phase-I and Phase-II metabolism in human, rat and dog.
Nevertheless, these reaction-document pairs may provide useful supervision for ranking.
PathText 2 was used to retrieve up to 1000 documents for each reaction, giving 530 reaction-document pairs.
To address this task, we manually annotated reaction-document pairs with the relevance of the documents to each reaction (Section 3.1).
In all, 3586 reaction-document pairs were annotated in five manually curated pathway models (Caron2010 mTOR SignalingNetwork, TLR ICSB, Kaizu2010 BuddingYeastCellCycle, Rb pathway3, EGFR signaling for RTKC) in the BioModels database.
We initially created a corpus of pathway reaction-document pairs manually annotated using four levels of relevance: N ot relevant, P artly relevant, R elevant and H ighly relevant (for detailed definitions, see Supplementary Material).
To explore the potential for previously released pathway annotations to support the ranking task, we extracted reaction-document pairs from PubMed IDs found in comments attached to pathway model reactions.
48 Overall, with the exception of a notably higher rate of mild injection site reactions documented in patients receiving the 22.5 mg dosage, there were no substantial differences between the side effect profile of patients treated with the different depot formulations (Table 2).
